P. Lio, “Tralokinumab Real-World Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis Adult Patients in the United States: 6-Month Interim Analysis”, J of Skin, vol. 8, no. 1, p. s318, Jan. 2024.